86 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ZVRA

Zevra Therapeutics
US$4.816.4%-2.0%US$198.8mUS$19.00PS7.3xE63.6%n/a

RCEL

AVITA Medical
US$8.752.7%-46.5%US$225.0mUS$25.90PS4.5xE62.0%n/a

ARDX

Ardelyx
US$8.7235.8%89.2%US$2.0bUS$13.39PS12.8xE62.9%n/a

FOLD

Amicus Therapeutics
US$10.401.2%-14.4%US$3.1bUS$18.78PS7.7xE55.6%n/a

OPTN

OptiNose
US$1.0117.4%-49.5%US$99.2mUS$3.75PS1.6xE59.9%n/a

ACAD

ACADIA Pharmaceuticals
US$17.052.0%-22.3%US$2.8bUS$28.75PS3.9xE40.8%n/a

SPPI

Spectrum Pharmaceuticals
US$1.035.3%17.0%US$209.9mUS$1.26PS8.2xE67.3%n/a

OCUP

Ocuphire Pharma
US$1.9923.6%-67.8%US$47.4mUS$19.50PS2.7xE9.5%n/a

ESPR

Esperion Therapeutics
US$2.089.5%48.6%US$390.2mUS$7.41PS3.4xE59.5%n/a

RVNC

Revance Therapeutics
US$3.9516.2%-88.6%US$392.9mUS$16.33PS1.8xE67.8%n/a

GBT

Global Blood Therapeutics
US$68.490.6%169.5%US$4.6bUS$68.50PS19.7xE66.2%n/a

HROW

Harrow
US$10.38-1.4%-61.7%US$376.3mUS$25.65PS2.8xE67.2%n/a

ARCT

Arcturus Therapeutics Holdings
US$27.272.7%0.6%US$714.1mUS$67.89PS4.4xE60.0%n/a

ADMA

ADMA Biologics
US$6.814.0%96.8%US$1.6bUS$8.38PS6.1xE32.5%n/a

TLRY

Tilray Brands
US$2.1018.0%-24.2%US$1.6bUS$2.37PS2.3xE86.1%n/a

GTHX

G1 Therapeutics
US$4.4912.5%45.8%US$232.2mUS$8.50PS2.8xE41.0%n/a

CDXC

ChromaDex
US$3.789.9%177.9%US$283.9mUS$6.08PS3.4xE93.2%n/a

AMPH

Amphastar Pharmaceuticals
US$42.463.3%16.4%US$2.1bUS$62.60PE15.1xE19.0%n/a

ICPT

Intercept Pharmaceuticals
US$19.000.1%19.1%US$794.7mUS$19.00PS2.5xE42.4%n/a

XERS

Xeris Biopharma Holdings
US$1.898.0%-21.3%US$275.8mUS$4.75PS1.7xE62.1%n/a

BCRX

BioCryst Pharmaceuticals
US$4.457.0%-48.0%US$924.4mUS$12.20PS2.8xE64.2%n/a

IRWD

Ironwood Pharmaceuticals
US$8.123.8%-23.9%US$1.3bUS$17.40PS2.9xE70.6%n/a

AMRN

Amarin
US$0.914.0%-34.5%US$377.2mUS$1.00PS1.3xE59.6%n/a

LFCR

Lifecore Biomedical
US$6.39-3.1%45.2%US$194.0mUS$6.00PS1.9xE138.1%n/a
Page 1 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.